Table 3 Associations of De Ritis with poor functional outcomes at discharge and 3 months follow-up.

From: Relationship between De Ritis and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage: Insights from the LongTEAM registry

Outcomes

P = 0.1

P = 0.5

knot

p-overall

p-non-linear

knot

p-overall

p-non-linear

Death at discharge

-

-

-

-

-

-

mRS 3–6 at discharge

7

0.173

0.118

7

0.173

0.118

mRS 4–6 at discharge

7

0.060

0.041

7

0.060

0.041

Death at 90 days

4

0.099

0.182

4

0.099

0.182

mRS 3–6 at 90 days

3

0.356

0.748

3

0.356

0.748

mRS 4–6 at 90 days

3

0.319

0.706

3

0.319

0.706

Intracranial infection

3

0.300

0.130

3

0.300

0.130

MACE

5

0.004

0.002

5

0.004

0.002

Stress ulcer bleeding

3

0.642

0.368

3

0.642

0.368

Abnormal hepatic function

6

0.002

0.008

6

0.002

0.008

UTI

3

0.900

0.881

3

0.900

0.881

Anemia

5

0.032

0.036

5

0.032

0.036

Hypoproteinemia

3

0.281

0.839

3

0.281

0.839

Pneumonia

3

0.336

0.229

3

0.336

0.229

DVT

3

0.162

0.065

3

0.162

0.065

Electrolyte disturbance

3

0.182

0.527

3

0.182

0.527

Disorders of lipoprotein metabolism

3

0.006

0.030

3

0.006

0.030

DCI

6

0.133

0.114

6

0.133

0.114

  1. mRS modified Rankin Scale; MACE major adverse cardiac event; UTI urinary tract infection; DVT deep venous thrombosis; DCI delayed cerebral ischemia.